Merseyside Mother Overcomes Chocolate Addiction with Mounjaro Trial, Sheds Seven Stone
After dropping her children at school each morning, Danielle Tanner, a 41-year-old from Wirral, Merseyside, would embark on a daily ritual of consuming fistfuls of chocolate bars until bedtime. This sugar addiction led her to weigh 16 stone 6lb at her heaviest, with a size 20 frame resulting from eating at least 15 chocolate bars daily. She described her routine: ‘After the school run, I’d eat eight Orange Clubs and two Twix bars. After lunch, four Toffee Crisps, another chocolate bar after dinner, and a box of Maltesers in bed. If I was working, I’d walk home eating four more chocolate bars.’
A Wake-Up Call and Medical Intervention
Ms Tanner decided to address her weight after her doctor warned she was morbidly obese, kickstarting a year-long journey. In January 2025, she was enrolled in a clinical trial using Mounjaro, a weight loss medication, rather than being sent away with minimal support. She noticed results almost immediately: ‘The first day, my head was quiet. I had a salad, trying to be healthy, and I just couldn’t finish it. I hardly snacked; the desire just left my body. I didn’t change my diet, just shrunk my portion sizes—that’s why it worked so well.’
Dramatic Transformation and Health Improvements
Fifteen months later, Ms Tanner weighs just 9 stone 10lb, having ditched her tent-like clothes for slinky size 10 outfits. She claims to look and feel years younger: ‘Since losing weight, people tell me I look 10 years younger. I actually feel it too—I’m 41, but I feel 31.’ By September 2025, she had lost six stone, weighing 10 stone 6lb, lighter than on her wedding day. When the programme ended in January 2026, she had shed a total of 6 stone 10lb, dropped 56 inches from her body, gone from a size 20 to 10, and reduced her BMI from 42.1 to 24.9.
As the weight fell off, her life transformed. She took up walking, cycling, swimming, indoor climbing, and even completed a Ninja Warrior course. She later switched to Wegovy after a price rise and has now been jab-free for three weeks. Follow-up tests show her cholesterol levels are normal, and her health is much improved.
Understanding Mounjaro and Overcoming Stigma
Mounjaro is a GLP-1 (glucagon-like peptide-1) drug that mimics hormones controlling blood sugar and appetite. Users report it affects the brain’s reward centre, helping them turn away from vices like wine and chocolate. Ms Tanner emphasized moderation: ‘If I want chocolate, I have one bar. Pizza? A couple of slices, not the whole thing.’ She addressed fears about relapse: ‘People worry you’ll put the weight back on when you stop the injections. You won’t—as long as you don’t go back to old habits. Using medication to help obese people shouldn’t have a stigma. Is it cheating? Absolutely not.’
Background and Broader Context
Ms Tanner’s struggle with food began at 18 after giving birth to her first child, with financial pressures and independence leading to binge eating. She tried Slimming World but struggled with cooking and motivation. She described her need for chocolate as an addiction: ‘I was like an alcoholic, but my “alcohol” was chocolate. It was a dopamine rush, and I just couldn’t stop.’
To celebrate her weight loss, she and her husband recreated their wedding photos: ‘My dress fit perfectly and laced up tighter than the first time around. My husband is happy, not because of how I look but because I’m happier. My motivation is back, my laziness gone. I make sure I get my 10,000 steps every day. It’s like hitting a reset button.’
Under official guidelines, Mounjaro is prescribed on the NHS only to patients with a BMI over 40 and weight-related health problems, but tens of thousands use it privately. In 2024, health chiefs announced a phased rollout over 12 years to provide Mounjaro to millions of obese patients, as weight-related illness costs the economy £74 billion annually. Two in three Britons are overweight or obese, with NHS figures showing people now weigh about a stone more than 30 years ago.
